TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Zora Biosciences Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
2,066
|
6,029
|
10,124 |
Financial expenses |
899
|
375
|
285 |
Earnings before taxes |
-8,639
|
-3,581
|
-4,035 |
Total assets |
45,979
|
36,668
|
35,483 |
Current assets |
1,282
|
1,398
|
2,407 |
Current liabilities |
4,803
|
3,289
|
5,424 |
Equity capital |
2,755
|
2,375
|
6,204 |
- share capital |
574
|
548
|
571 |
Employees (average) |
14
![]() |
14 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
6.0%
|
6.5%
|
17.5% |
Turnover per employee |
148
|
431 | |
Profit as a percentage of turnover |
-418.2%
|
-59.4%
|
-39.9% |
Return on assets (ROA) |
-16.8%
|
-8.7%
|
-10.6% |
Current ratio |
26.7%
|
42.5%
|
44.4% |
Return on equity (ROE) |
-313.6%
|
-150.8%
|
-65.0% |
Change turnover |
-4,248
|
-3,691
|
2,940 |
Change turnover % |
-67%
|
-38%
|
41% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.